Iovance Biotherapeutics (IOVA) P/FCF US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
P/FCF | -20.8 | -25.5 | -11.0 | -3.25 | -4.98 | -3.15 | |||
Changes by years, y/y, % | +147% | +23% | -57% | -71% | +53% | -9.9% |
Iovance Biotherapeutics. P/FCF
Iovance Biotherapeutics. P/FCF, changes, %
Iovance Biotherapeutics (IOVA) P/FCF US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
P/FCF | -2.96 | -5.42 | -9.74 | -5.70 | -7.61 | -3.15 | ||
Changes by years, y/y, % | -42% | +61% | +149% | +28% | +157% | |||
Changes by quarters, q/q, % | -33% | +83% | +80% | -41% | +33% |